Hepatic manifestations of COVID-19 and effect of remdesivir on liver function in patients with COVID-19 illness-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hepatic manifestations of COVID-19 and effect of remdesivir on liver function in patients with COVID-19 illness

Published:2021-03-08 Issue:4 Volume:34 Page:473-477
ISSN:0899-8280
Container-title:Baylor University Medical Center Proceedings
language:en
Short-container-title:Baylor University Medical Center Proceedings

Author:

Aleem Abdul¹,Mahadevaiah Guruprasad²,Shariff Nasir³,Kothadia Jiten P.⁴

Affiliation:

1. Gastroenterology and Hepatology, Lehigh Valley Health Network, Allentown, Pennsylvania

2. Cardiology, California Northstate University College of Medicine, Sacramento, California

3. Cardiology, CHI Franciscan Heart and Vascular Associates, Tacoma, Washington

4. Transplant Hepatology, James D. Eason Transplant Institute, University of Tennessee Health Sciences Center, Memphis, Tennessee

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/08998280.2021.1885289

Reference35 articles.

1. COVID-19, SARS and MERS: are they closely related?

2. Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis

3. Liver injury during highly pathogenic human coronavirus infections

4. Liver injury in COVID-19: management and challenges

5. COVID-19 and the liver

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanistic Understanding of Dexamethasone-Mediated Protection against Remdesivir-Induced Hepatotoxicity;Molecular Pharmacology;2024-05-20

2. Differences in Glutamate Dehydrogenase (GLDH) and Other Liver Biochemistry Levels before and after Remdesivir Treatment in COVID-19;Research Journal of Pharmacy and Technology;2024-04-22

3. The metabolic footprint of Vero E6 cells highlights the key metabolic routes associated with SARS-CoV-2 infection and response to drug combinations;Scientific Reports;2024-04-04

4. Remdesivir and the Liver: A Concise Narrative Review of Remdesivir-Associated Hepatotoxicity in Patients Hospitalized Due to COVID-19;Pharmacoepidemiology;2024-02-13

5. COVID-19, Possible Hepatic Pathways and Alcohol Abuse—What Do We Know up to 2023?;International Journal of Molecular Sciences;2024-02-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3